News + Publications
Hayat Biotech to lead conversation on role of biotechnology in healthcare at GITEX
09 December 2022
Senior Consultant at Group 42-Sinopharm BNCG biotech company, Dr Nawal Al Kaabi, to deliver key address at latest edition of tech event DUBAI, UNITED ARAB EMIRATES: Leading biotech scientist, Dr Nawal Al Kaabi, will today address assembled visitors to GITEX on the protection of societies and drug security, drawing on her personal expertise and experience, […]
Read MoreRole of biotechnology and life sciences in UAE’s healthcare ambitions
09 December 2022
AI, advanced data management and security privacy have played a fundamental role in reimagining the future of healthcare. Globally, the UAE ranked twentieth in the 2021 World Index of Healthcare Innovation. This is a strong showing for the country and not at all unexpected when we consider the proactive steps taken in recent years. The […]
Read MoreHRH the Crown Prince and Prime Minister meets with the Chairman of China National Pharmaceutical Group Corporation (Sinopharm)
09 December 2022
His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, today met with the Chairman of China National Pharmaceutical Group Corporation (Sinopharm), Liu Jingzhen, at Gudaibiya Palace. His Royal Highness highlighted the importance of internationally coordinated efforts to meet global health challenges, noting the Kingdom’s commitment to supporting initiatives to […]
Read MoreParents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates
10 October 2022
The United Arab Emirates had approved the COVID-19 vaccine for children. Assessing parents’ acceptance of the vaccine for their children will influence decision-making in the COVID-19 vaccine roll-out.
Read MorePathological sequelae of long-haul COVID
10 October 2022
The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants.
Read More